Company Interview / Ego-boost, with skincare brand expanding globally

Key points:

Ego Pharmaceuticals exports dermatological products to 20+ international marketsAustralian manufacturing and Therapeutic Goods Administration credibility aid global expansionOppenheim prioritises cohesive teams and bold, shared goalsChildhood inspirations shaped Oppenheim’s path in the skincare sector

Dr Jane Oppenheim of Ego Pharmaceuticals outlines her company’s extensive range of dermatological products, manufactured in Melbourne and exported to over 20 countries including the UK, Asia, and the Middle East. Oppenheim highlights Ego’s commitment to treating conditions such as eczema, psoriasis, and fungal infections, as well as sensitive and dry skin, with products like QV Facial Cleanser widely used by Australian families.

Oppenheim states a bold goal and unified team are central to her approach, likening leadership to orchestrating a group where communication and alignment are key. She describes her career journey at Ego, from developing new product formulas and advancing the manufacturing plant at Braeside, to fostering international demand for Ego’s products. Oppenheim regards Australia’s strong reputation and the Therapeutic Goods Administration as significant advantages when expanding internationally, noting the importance of building trust and compliance in new markets before local employment and education.

Reflecting on her personal trajectory, Oppenheim shares inspiration drawn from childhood role models such as Helena Rubinstein and Estée Lauder, and her lasting fulfilment at contributing to Australian manufacturing while realising her early ambitions within the global skincare industry.